Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tianjin Tianjiao Pharmaceutical is a pharmaceutical manufacturing company based in the Tianjin Economic-Technological Development Area, China. As a key subsidiary of the state-owned Tianjin Pharmaceutical Group, the company specializes in the production of chemical active pharmaceutical ingredients (APIs) and finished oral solid dosage forms. Its product portfolio is primarily focused on therapeutic areas such as cardiovascular health, respiratory diseases, and anti-infectives. The company operates modern, GMP-certified facilities that produce a variety of tablets, capsules, and granules for both domestic and international markets. Tianjin Tianjiao Pharmaceutical is recognized for its commitment to quality standards and its role as a core manufacturing unit within its parent conglomerate's supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tianjin Tianjiao Pharmaceutical.